trending Market Intelligence /marketintelligence/en/news-insights/trending/mylkajy-hpmpjsjuy78ppa2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Russia grants Proteomics International patent for diabetic kidney disease test

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Russia grants Proteomics International patent for diabetic kidney disease test

Medtech company Proteomics International Laboratories Ltd. said Russia granted the company a patent for PromarkerD, its diagnostic and prognostic test for diabetic kidney disease.

The patent took effect Aug. 10 and will remain effective until Sept. 20, 2031.

PromarkerD has been granted patent protection in Australia, Singapore, China and the U.S.